|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
|
|---|---|---|---|
| Cash and Bank | |||
| Total current assets | |||
| TOTAL ASSETS | |||
| Convertible notes payable | |||
| Accrued Interest Payable | |||
| Total current liabilities | |||
| Total other liabilities | |||
| TOTAL LIABILITIES | |||
| Preferred Stock, Value, Issued | |||
| Series A Preferred Stock | |||
| Series B Preferred Stock | |||
| Common stock, par value $0.0001 - authorized 5,000,000,000 shares 4,024,163,151 and 3,674,163,151 shares issued and outstanding as of June 30, 2026 and December 31, 2025 respectively | |||
| Additional paid-in-capital | |||
| Accumulated deficit | |||
| TOTAL STOCKHOLDERS' EQUITY | |||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |
Loading...
